|
Optimizing TCRαβ+/CD19+-depleted haploidentical HSCT for ALL using donor-derived genome-edited CAR T cells |
Stanford University School of Medicine / Alice Bertaina, MD/PhD |
Reach Grants |
2019 |
California |
|
Novel Therapy of Heterogeneous B-cell Acute Lymphocytic Leukemia by Targeting Convergent Oncogenic Mediators STATs |
University of Alberta / Hasan Uludag, PhD |
Innovation Grants |
2019 |
Alberta |
|
Determining Social Risk Factors for Poor Outcomes in Pediatric Cancer Using Children’s Oncology Group Registries |
University of Utah / Anne Kirchhoff, PhD/MPH |
Epidemiology Grants |
2019 |
Utah |
|
Preclinical Development of a First-in-Class PCNA Inhibitor for Treating Neuroblastoma |
City of Hope National Medical Center / Linda Malkas, PhD |
Reach Grants |
2019 |
California |
|
Targeting microenvironment-induced TGFB signaling to overcome drug resistance in acute lymphoblastic leukemia |
St. Jude Children's Research Hospital / Charles Mullighan, MD |
Innovation Grants |
2019 |
Tennessee |
|
Cancer Risk and Incidence in Beckwith-Wiedemann Syndrome |
Children's Hospital of Philadelphia / Jennifer Kalish, MD/PhD |
Epidemiology Grants |
2019 |
Pennsylvania |
|
Norepinephrine Transporter-Targeted Pharmacotherapy of Aggressive Neuroblastoma |
Children's Hospital of Philadelphia / Michael Chorny, PhD |
Innovation Grants |
2019 |
Pennsylvania |
|
Therapeutic Targets and Molecular Mechanisms in Childhood Brainstem Tumors |
University Health Network - Toronto Western Research Institute / Jerome Fortin, PhD |
Young Investigator Grants |
2019 |
Ontario |
|
Therapeutic Targeting of the Disrupted Metabolic State in DIPG |
University of Michigan / Costas Lyssiotis, PhD & Sriram Venneti, MD/PhD |
Innovation Grants |
2019 |
Michigan |
|
Bcl2-Family Inhibitors in Neuroblastoma: Mechanism of Action, Therapy Resistance, and Development of Biomarkers |
Children's Hospital of Philadelphia / Claudia Zapata, MD |
Young Investigator Grants |
2019 |
Pennsylvania |
